Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19114612 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes
Interventions: Drug: dapagliflozin;   Drug: placebo;   Drug: metformin
2 Not yet recruiting Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
Condition: Type2 Diabetes Mellitus
Intervention: Drug: Saxagliptin

Indicates status has not been verified in more than two years